In two separate orders, the state’s highest court blocked new hospital admitting privileges requirements and restrictions on medication abortions from taking effect while trials challenging their legality proceed.
Attorneys from the Center for Reproductive Rights filed an emergency appeal with the Oklahoma Supreme Court asking them to blocking a ruling Wednesday that allowed new restrictions on medication abortions to take effect.
The order gives attorneys for the state time to file a request with the U.S. Supreme Court to review an appeals court order blocking limitations on RU-486.
The study is the first academic evaluation of the impact of HB 2 to be released since the law passed last year.
A panel of judges is considering overturning a lower court’s ruling that the state’s 20-week abortion ban is unconstitutional.
The new southeast Dallas facility will be one of eight legal abortion providers left in Texas after September 1.
In a strongly worded opinion, the U.S. Court of Appeals for the Ninth Circuit said attorneys for Arizona failed to offer any evidence supporting the need for restrictions on medication abortions.
An emergency order prevented the requirements from taking effect in April, which would have required providers to strictly follow FDA protocol when administering abortion-inducing medications.
There’s only one remaining abortion clinic in Missouri—a Planned Parenthood facility in St. Louis—and anti-choice lawmakers are hell-bent on closing it, introducing nearly 40 anti-choice bills over the past two years.
The American Medical Association and the American Congress of Obstetricians and Gynecologists filed a friend of the court brief detailing how restrictions on medication abortion hurt patient safety and interfere with standards of medical care.